China Approves Its Homegrown COVID-19 Vaccine For Widespread Use

NPR | By Bill Chappell

Published December 31, 2020 at 8:27 AM MST

The state-owned Sinopharm says its vaccine has a 79% efficacy rate — surpassing the widely accepted standard of 50% efficacy.

NPR Coronavirus Updates

Bill Chappell

Bill Chappell is a writer and editor on the News Desk in the heart of NPR's newsroom in Washington, D.C.